Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells

Edward Curry; Ian Green; Nadine Chapman-Rothe; Elham Shamsaei; Sarah Kandil; Fanny L. Cherblanc; Luke Payne; Emma Bell; Thota Ganesh; Nitipol Srimongkolpithak; Joachim Caron; Fengling Li; Anthony G. Uren; James P. Snyder; Masoud Vedadi; Matthew J. Fuchter; Robert Brown

doi:10.1186/s13148-015-0118-9

Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells

Edward Curry
, Ian Green
, Nadine Chapman-Rothe
, Elham Shamsaei
, Sarah Kandil
, Fanny L. Cherblanc
, Luke Payne
, Emma Bell
, Thota Ganesh
, Nitipol Srimongkolpithak
, Joachim Caron
, Fengling Li
, Anthony G. Uren
, James P. Snyder
, Masoud Vedadi
, Matthew J. Fuchter
, Robert Brown^*

^*Corresponding author for this work

School of Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	0
Journal	Clinical Epigenetics
Volume	7
Issue number	1
Early online date	21 Aug 2015
DOIs	https://doi.org/10.1186/s13148-015-0118-9
Publication status	Published - Dec 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/s13148-015-0118-9

Cite this

Curry, E., Green, I., Chapman-Rothe, N., Shamsaei, E., Kandil, S., Cherblanc, F. L., Payne, L., Bell, E., Ganesh, T., Srimongkolpithak, N., Caron, J., Li, F., Uren, A. G., Snyder, J. P., Vedadi, M., Fuchter, M. J., & Brown, R. (2015). Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells. Clinical Epigenetics, 7(1). https://doi.org/10.1186/s13148-015-0118-9

@article{9fd57ac0572e41009f6ec47b00a6611d,

title = "Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells",

author = "Edward Curry and Ian Green and Nadine Chapman-Rothe and Elham Shamsaei and Sarah Kandil and Cherblanc, \{Fanny L.\} and Luke Payne and Emma Bell and Thota Ganesh and Nitipol Srimongkolpithak and Joachim Caron and Fengling Li and Uren, \{Anthony G.\} and Snyder, \{James P.\} and Masoud Vedadi and Fuchter, \{Matthew J.\} and Robert Brown",

year = "2015",

month = dec,

doi = "10.1186/s13148-015-0118-9",

language = "English",

volume = "7",

journal = "Clinical Epigenetics",

issn = "1868-7075",

publisher = "BioMed Central Ltd.",

number = "1",

}

Curry, E, Green, I, Chapman-Rothe, N, Shamsaei, E, Kandil, S, Cherblanc, FL, Payne, L, Bell, E, Ganesh, T, Srimongkolpithak, N, Caron, J, Li, F, Uren, AG, Snyder, JP, Vedadi, M, Fuchter, MJ & Brown, R 2015, 'Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells', Clinical Epigenetics, vol. 7, no. 1. https://doi.org/10.1186/s13148-015-0118-9

TY - JOUR

T1 - Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells

AU - Curry, Edward

AU - Green, Ian

AU - Chapman-Rothe, Nadine

AU - Shamsaei, Elham

AU - Kandil, Sarah

AU - Cherblanc, Fanny L.

AU - Payne, Luke

AU - Bell, Emma

AU - Ganesh, Thota

AU - Srimongkolpithak, Nitipol

AU - Caron, Joachim

AU - Li, Fengling

AU - Uren, Anthony G.

AU - Snyder, James P.

AU - Vedadi, Masoud

AU - Fuchter, Matthew J.

AU - Brown, Robert

PY - 2015/12

Y1 - 2015/12

U2 - 10.1186/s13148-015-0118-9

DO - 10.1186/s13148-015-0118-9

M3 - Article

SN - 1868-7075

VL - 7

JO - Clinical Epigenetics

JF - Clinical Epigenetics

IS - 1

ER -